Literature DB >> 18216607

The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury.

Mark Coburn1, Mervyn Maze, Nicholas P Franks.   

Abstract

OBJECTIVES: The "inert" gas xenon has been shown to be an effective neuroprotectant in a variety of in vitro and in vivo models of neuronal injury. We examined its neuroprotective properties in an in vitro model of traumatic brain injury.
DESIGN: Controlled laboratory study.
SETTING: Academic research laboratory.
SUBJECTS: Organotypic hippocampal brain slices from mice pups.
INTERVENTIONS: The cultured brain slices were subjected to a focal mechanical trauma, and injury was monitored in the presence and absence of inert gases at normal and elevated pressures and under both normothermic and hypothermic conditions.
MEASUREMENTS AND MAIN RESULTS: Neuronal injury was quantified using propidium iodide, which becomes fluorescent only when it enters injured cells. Low pressures of both helium and xenon were effective neuroprotectants when applied in addition to 1 atm of air. Moreover, both gases were effective at normal pressures when they replaced nitrogen in a gas mixture.
CONCLUSIONS: The inert gases helium and xenon are effective neuroprotectants in a model for traumatic brain injury, and this novel treatment warrants further investigation. Xenon was particularly effective at reducing the secondary injury that developed following the initial trauma and could be administered at least 3 hrs postinjury with only a small reduction in efficacy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216607     DOI: 10.1097/01.CCM.0B013E3181611F8A6

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  47 in total

Review 1.  [Current developments in xenon research. Importance for anesthesia and intensive care medicine].

Authors:  A Brücken; M Coburn; S Rex; R Rossaint; M Fries
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

2.  Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Michael Czaplik; Yu-Mi Ryang; Markus Kipp; Rolf Rossaint; Cordian Beyer
Journal:  Inflamm Res       Date:  2010-11-23       Impact factor: 4.575

Review 3.  Molecular approaches to improving general anesthetics.

Authors:  Stuart A Forman
Journal:  Anesthesiol Clin       Date:  2010-12

Review 4.  [Neuroprotection by noble gases: New developments and insights].

Authors:  A V Fahlenkamp; R Rossaint; M Coburn
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

Review 5.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

6.  Xenon enhances LPS-induced IL-1β expression in microglia via the extracellular signal-regulated kinase 1/2 pathway.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Hajo Haase; Markus Kipp; Yu-Mi Ryang; Rolf Rossaint; Cordian Beyer
Journal:  J Mol Neurosci       Date:  2010-08-03       Impact factor: 3.444

7.  Morphine reduces the threshold of helium preconditioning against myocardial infarction: the role of opioid receptors in rabbits.

Authors:  Paul S Pagel; John G Krolikowski; Julien Amour; David C Warltier; Dorothee Weihrauch
Journal:  J Cardiothorac Vasc Anesth       Date:  2009-02-23       Impact factor: 2.628

8.  Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury.

Authors:  Anna B Roehl; Marc Hein; Philipp D Loetscher; Jan Rossaint; Joachim Weis; Rolf Rossaint; Mark Coburn
Journal:  BMC Neurol       Date:  2010-10-21       Impact factor: 2.474

Review 9.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

10.  Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Authors:  Philip D Loetscher; Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Astrid Fahlenkamp; Yu-Mi Ryang; Oliver Grottke; Mark Coburn
Journal:  Crit Care       Date:  2009-12-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.